Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.
Gotto AM Jr, Boccuzzi SJ, Cook JR, Alexander CM, Roehm JB, Meyer GS, Clearfield M, Weis S, Whitney E. Gotto AM Jr, et al. Among authors: whitney e. Am J Cardiol. 2000 Dec 1;86(11):1176-81. doi: 10.1016/s0002-9149(00)01198-x. Am J Cardiol. 2000. PMID: 11090787 Free article. Clinical Trial.
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS. Gotto AM Jr, et al. Among authors: whitney e. Circulation. 2000 Feb 8;101(5):477-84. doi: 10.1161/01.cir.101.5.477. Circulation. 2000. PMID: 10662743 Clinical Trial.
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, Jou JY, Langendörfer A, Beere PA, Watson DJ, Downs JR, de Cani JS. Gotto AM Jr, et al. Among authors: whitney e. Eur Heart J. 2000 Oct;21(19):1627-33. doi: 10.1053/euhj.2000.2288. Eur Heart J. 2000. PMID: 10988016 Clinical Trial.
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Downs JR, et al. Among authors: whitney e. JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615. JAMA. 1998. PMID: 9613910 Clinical Trial.
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women.
Clearfield M, Downs JR, Weis S, Whitney EJ, Kruyer W, Shapiro DR, Stein EA, Langendorfer A, Beere PA, Gotto AM. Clearfield M, et al. Among authors: whitney ej. J Womens Health Gend Based Med. 2001 Dec;10(10):971-81. doi: 10.1089/152460901317193549. J Womens Health Gend Based Med. 2001. PMID: 11788107 Clinical Trial.
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).
Zhao XQ, Krasuski RA, Baer J, Whitney EJ, Neradilek B, Chait A, Marcovina S, Albers JJ, Brown BG. Zhao XQ, et al. Am J Cardiol. 2009 Dec 1;104(11):1457-64. doi: 10.1016/j.amjcard.2009.07.035. Am J Cardiol. 2009. PMID: 19932775 Free PMC article.
230 results